SABRIL (vigabatrin) is a prescription medicine used with various other therapies in youngsters and adults 2 years old and older with refractory complicated partial seizures (CPS) who have actually not reacted well enough to numerous other therapies and if the feasible benefits surpass the danger of vision loss.
It is recommended that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after starting SABRIL and at least every 3 months throughout therapy until SABRIL is quit. Inform your healthcare provider if you or your youngster have any negative effects that bothers you or that does not vanish.
Tell your doctor as soon as possible if seizures get worse. If you ought to take SABRIL while you are expecting, you and your health care provider will have to make a decision. The most common side effects of SABRIL in adults include: blurred vision, drowsiness, wooziness, troubles strolling or feeling uncoordinated, shaking (trembling), and fatigue.